CD138

From Libre Pathology
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

CD138, also known as Syndecan-1 (abbreviated SDC1),[1] is an immunostain that marks plasma cells.

It plays a role in angiogenesis and cellular proliferation.[2]

Positive

Variable

  • Adenocarcinoma - often positive in primaries from gastrointestinal tract, female reproductive organs and breast.[6]

Negative

See also

References

  1. Online 'Mendelian Inheritance in Man' (OMIM) 186355
  2. Guo, Q.; Yang, X.; Ma, Y.; Ma, L. (2015). "Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.". Eur J Gynaecol Oncol 36 (5): 506-13. PMID 26513873.
  3. Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 554. ISBN 978-0781765275.
  4. Lim, GH.; Tan, PH.; Jara-Lazaro, AR.; Thike, AA.; Sim, WC.; Yap, VB.; Yip, GW. (Sep 2014). "Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival.". Singapore Med J 55 (9): 468-72. PMID 25273930.
  5. Zhang, W.; Jiang, YX.; Liu, Y.; Yu, WJ.; Zhao, H.; Li, YJ. (Jul 2013). "[Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].". Zhonghua Bing Li Xue Za Zhi 42 (7): 433-7. PMID 24246859.
  6. 6.0 6.1 Chu, PG.; Arber, DA.; Weiss, LM. (Jul 2003). "Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases.". Am J Clin Pathol 120 (1): 64-70. doi:10.1309/48KC-17WA-U69B-TBXQ. PMID 12866374.

.